General Information of the Compound
| Compound ID |
CP0575346
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
N-methyl-5-[7-(1-methylpyrazol-4-yl)-6-(oxolan-3-yloxy)imidazo[1,2-b]pyridazin-3-yl]pyridine-3-carboxamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C21H21N7O3
|
||||||||||||||||||
| Molecular Weight |
419.445
|
||||||||||||||||||
| Canonical SMILES |
CNC(=O)c1cncc(c1)-c1cnc2cc(-c3cnn(C)c3)c(OC3CCOC3)nn12
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C21H21N7O3/c1-22-20(29)14-5-13(7-23-8-14)18-10-24-19-6-17(15-9-25-27(2)11-15)21(26-28(18)19)31-16-3-4-30-12-16/h5-11,16H,3-4,12H2,1-2H3,(H,22,29)
Show/Hide
|
||||||||||||||||||
| InChIKey |
XNMAPUNKOCMYMH-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01411, Fibroblast growth factor receptor 3
Protein ID: PT06924, Fibroblast growth factor receptor 3